Influence of genotype on dopamine transporter availability in human striatum and sleep architecture

Psychiatry Research

Volumn 179, Issue 2, 2010, Pages 238-240

  Guindalini, Camila ^a   Martins, Raquel Cristina ^a   Andersen, Monica L ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DAT gene; Dopamine; Polymorphism; Sleep; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DNA POLYMORPHISM; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INTRON; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REM SLEEP; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP PATTERN; VARIABLE NUMBER OF TANDEM REPEAT; ANALYSIS OF VARIANCE; DIAGNOSTIC USE; EYE MOVEMENT; GENETICS; PHYSIOLOGY; PROCEDURES; SCINTISCANNING; SLEEP; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EYE MOVEMENTS; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MINISATELLITE REPEATS; ORGANOTECHNETIUM COMPOUNDS; SLEEP; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 77956182619     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.07.017     Document Type: Article

References (24)

1. Asherson P., Brookes K., Franke B., Chen W., Gill M., Ebstein R.P., Buitelaar J., Banaschewski T., Sonuga-Barke E., Eisenberg J., Manor I., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Faraone S.V. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. American Journal of Psychiatry 2007, 164:674-677.
2. Boivin D.B. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. Journal of Psychiatry and Neuroscience 2000, 25:446-458.
3. Brookes K.J., Mill J., Guindalini C., Curran S., Xu X., Knight J., Chen C.K., Huang Y.S., Sethna V., Taylor E., Chen W., Breen G., Asherson P. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Archives of General Psychiatry 2006, 63:74-81.
4. Brookes K.J., Neale B.M., Sugden K., Khan N., Asherson P., D'Souza U.M. Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144:1070-1078.
5. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 1978, 25:638-643.
6. D'Souza U.M., Craig I.W. Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Progress in Brain Research 2008, 172:73-98.
7. Franken P., Tafti M. Genetics of sleep and sleep disorders. Frontiers in Bioscience 2003, 8:381-397.
8. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annual Review of Pharmacology and Toxicology 2003, 43:261-284.
9. Gelernter J., Kranzler H.R., Satel S.L., Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994, 11:195-200.
10. Goudreau J.L., Maraganore D.M., Farrer M.J., Lesnick T.G., Singleton A.B., Bower J.H., Hardy J.A., Rocca W.A. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Movement Disorders 2002, 17:1305-1311.
11. Guindalini, C., 2006. Genetics and Pharmacogenetics of Cocaine Addiction. London, United Kingdom. Phd Dissertation, University of London, King's College London.
12. Guindalini C., Howard M., Haddley K., Laranjeira R., Collier D., Ammar N., Craig I., O'Gara C., Bubb V.J., Greenwood T., Kelsoe J., Asherson P., Murray R.M., Castelo A., Quinn J.P., Vallada H., Breen G. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proceedings of the National Academy of Sciences 2006, 103:4552-4557.
13. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., Weinberger D.R. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
14. Iber C., Ancoli-Israel S., Chesson A.L., Quan S.F. The AASM Manual for the Scoring of Sleep and Associated Events: rules. Terminology and Technical Specifications. American Academy of Sleep Medicine 2007, Westchester, Illinois, US.
15. Kelada S.N., Costa-Mallen P., Checkoway H., Carlson C.S., Weller T.S., Swanson P.D., Franklin G.M., Longstreth W.T., Afsharinejad Z., Costa L.G. Dopamine transporter SLC6A3 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenetics and Genomics 2005, 15:659-668.
16. Laucht M., Skowronek M.H., Becker K., Schmidt M.H., Esser G., Schulze T.G., Rietschel M. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Archives of General Psychiatry 2007, 64:585-590.
17. Lynch D.R., Mozley P.D., Sokol S., Maas N.M., Balcer L.J., Siderowf A.D. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Movements Disorders 2003, 18:804-812.
18. Martinez D., Gelernter J., Abi-Dargham A., van Dyck C.H., Kegeles L., Innis R.B., Laruelle M. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001, 24:553-560.
19. Mill J., Asherson P., Craig I., D'Souza U.M. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genetics 2005, 6:3.
20. Monti J.M., Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Medicine Reviews 2007, 11:113-133.
21. Payton A., Holmes J., Barrett J.H., Sham P., Harrington R., McGuffin P., Owen M., Ollier W., Worthington J., Thapar A. Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins. Psychiatry Research 2001, 105:273-278.
22. Shih M.C., Amaro E., Ferraz H.B., Hoexter M.Q., Goulart F.O., Wagner J., Lin L.F., Fu Y.K., Mari J.J., de Lacerda A.L., Tufik S., Bressan R.A. Neuroimaging of the dopamine transporter in Parkinson's disease - first study using [99mTc]-TRODAT-1 and SPECT in Brazil. Arquivos de Neuro-Psiquiatria 2006, 64:628-634.
23. Tufik S., Lindsey C.J., Carlini E.A. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?. Pharmacology 1978, 16:95-108.
24. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., Uhl G.R. Human dopamine transporter gene DAT1 maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14:1104-1106.